Puriq Cidal® (Ciprofloxacin)
Attributes
| Category | Generic Name | Brand |
|---|---|---|
| Antibacterial Drugs | Ciprofloxacin | Puriq Cidal® |
| Dosage Form | Dosage | Packing |
| Tablet | 500 mg | 60 |
Puriq Cidal® (Ciprofloxacin)
 |
General Description | – |
|
Side Effects | Common adverse effects are as follow: 1-10% Nausea (3%), Abdominal pain (2%), Diarrhea (2% adults; 5% children), Increased aminotransferase levels (2%), Vomiting (1% adults; 5% children), Headache (1%), Increased serum creatinine (1%), Rash (2%), Restlessness (1%) <1% Acidosis, Allergic reaction, Angina pectoris, Anorexia, Arthralgia, Ataxia, Back pain, Bad taste, Blurred vision, Breast pain, Bronchospasm, Diplopia, Dizziness, Drowsiness, Dysphagia, Dyspnea, Flushing, Foot pain, Hallucinations, Hiccups, Hypertension, Hypotension, Insomnia, Irritability, Joint stiffness, Lethargy, Migraine, Nephritis, Nightmares, Oral candidiasis, Palpitation, Photosensitivity, Polyuria, Syncope, Tachycardia, Tinnitus, Tremor, Urinary retention, Vaginitis |
|
Direction of use | Adult: 1) Acute Sinusitis Mild/moderate: 500 mg PO q12hr Limitations-of-use: Reserve fluoroquinolones for patients who do not have other available treatment options for acute sinusitis 2) Bone & Joint Infections Mild/moderate: 500 mg PO q12hr for ≥4-6 weeks Severe/complicated: 750 mg PO q12hr for ≥4-6 weeks 3) Chronic Bacterial Prostatitis Indicated for chronic bacterial prostatitis caused by Escherichia coli or Proteus mirabilis Mild/moderate: 500 mg PO q12hr for 28 days 4) Infectious Diarrhea Mild/moderate/severe: 500 mg PO q12hr for 5-7 days 5) Intra-abdominal Infections Complicated: 500 mg PO q12hr for 7-14 days 6) Lower Respiratory Tract Infections Mild/moderate: 500 mg PO q12hr for 7-14 days Severe/complicated: 750 mg PO q12hr for 7-14 days Limitations-of-use: Reserve fluoroquinolones for patients who do not have other available treatment options for acute bacterial exacerbation of chronic bronchitis. 7) Skin/Skin Structure Infections Mild/moderate: 500 mg PO q12hr for 7-14 days Severe/complicated: 750 mg PO q12hr for 7-14 days 8) Urinary Tract Infections Acute uncomplicated: Immediate-release, 250 mg PO q12hr for 3 days; Mild/moderate: 250 mg PO q12hr for 7-14 days Severe/complicated: 500 mg PO q12hr for 7-14 days Limitations-of-use: Reserve fluoroquinolones for patients who do not have other available treatment options for uncomplicated urinary tract infections 9) Urethral & Cervical Gonococcal Infections Uncomplicated: 250-500 mg PO once 10) Anthrax Infection Cutaneous: 500 mg PO q12hr for 60 days 11) Plague Indication for treatment and prophylaxis of plague due to Yersinia pestis 500-750 mg PO q12hr x14 days |
|
Warnings | Fluoroquinolones have been associated with disabling and potentially irreversible serious adverse reactions that have occurred together including: tendinitis and tendon rupture, peripheral neuropathy, and CNS effects. Discontinue the drug immediately and avoid use of systemic fluoroquinolones in patients who experience any of these serious adverse reactions. May exacerbate muscle weakness in patients with myasthenia gravis; avoid fluoroquinolones with known history of myasthenia gravis. Documented hypersensitivity; concurrent tizanidine administration |
|
Catalog | Puriq Cidal® (Ciprofloxacin) Catalog |